TL;DR
Therapeutic agents loaded in LLC nanoassemblies offer qualitative and quantitative enhancements that are superior to conventional chemotherapy, particularly in terms of preferential accumulation at tumor sites and promoting enhanced cancer cell uptake, lowering tumor volume and weight, improving survival rates, and increasing the cytotoxicity of their loaded therapeutic agents.
AI-generated by Semantic Scholar
Authors
Henrique Araújo-Silva, Patricia V. Teixeira, Andreia C. Gomes, Marlene Lúcio, Carla M. Lopes
